Global Disposable Insulin Pumps Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Disposable Insulin Pumps Market Analysis  

The disposable insulin pumps market is experiencing significant growth, driven by rising diabetes prevalence and increasing demand for innovative, user-friendly devices. With the global diabetes population projected to reach 643 million by 2030, the need for effective insulin delivery systems is more critical than ever. Recent developments in the market include the introduction of advanced disposable insulin pumps featuring integrated continuous glucose monitoring (CGM) systems, which enhance glucose management and provide real-time data to users. Companies are focusing on user-centric designs, such as tubeless and lightweight models, that improve convenience and reduce the burden of managing diabetes. Furthermore, regulatory approvals for new disposable insulin delivery systems, such as the recent FDA clearance of several cutting-edge products, are expanding market access and increasing consumer confidence. Collaborations between tech companies and healthcare providers are also accelerating innovation, leading to the development of smart insulin pumps that connect with mobile applications for better diabetes management. As awareness of diabetes management continues to rise, the disposable insulin pumps market is poised for robust growth, enhancing the quality of life for individuals with diabetes.

Disposable Insulin Pumps Market Size

The global disposable insulin pumps market size was valued at USD 3.57 billion in 2023 and is projected to reach USD 6.50 billion by 2031, with a CAGR of  7.77% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Disposable Insulin Pumps Market Trends

“Increasing Smart Technology Integration”

The disposable insulin pumps market is gaining traction as patients seek convenient and cost-effective solutions for diabetes management. A prominent trend in the  market is the increasing shift towards smart technology integration, enhancing the functionality and user experience of these devices. These advanced insulin pumps now often feature wireless connectivity, allowing patients to monitor their glucose levels and manage insulin delivery through smartphone applications. For instance, devices such as Omnipod DASH have gained traction by providing a tubeless design with real-time data tracking, which improves patient adherence and ease of use. As diabetes management becomes more personalized, the demand for disposable insulin pumps with advanced features, such as automated insulin dosing and data sharing with healthcare providers, is rising. Such trend highlights the growing importance of technology in providing effective and convenient treatment options for patients with diabetes.

Report Scope and Disposable Insulin Pumps Market Segmentation  

Disposable Insulin Pumps Market Definition

Disposable insulin pumps are compact, portable devices designed to deliver precise doses of insulin to individuals with diabetes, they are designed for single-use and come pre-filled with insulin. These pumps often feature user-friendly interfaces and are equipped with technology to facilitate easy insulin administration, helping to manage blood glucose levels effectively. They may also include advanced functionalities, such as integration with continuous glucose monitoring systems, enabling real-time glucose tracking and automated insulin delivery. T Their ease of use and convenience make disposable insulin pumps a popular choice for patients looking for a straightforward way to manage their diabetes.

Disposable Insulin Pumps Market Dynamics

Drivers

• Rising Prevalence of Diabetes

The rising prevalence of diabetes is a significant driver for the disposable insulin pumps market, as the increasing global incidence of both type 1 and type 2 diabetes necessitates effective insulin delivery systems. According to the International Diabetes Federation, over 537 million adults were living with diabetes in 2021, and this number is projected to reach 783 million by 2045. This alarming trend underscores the urgent need for innovative diabetes management solutions, including disposable insulin pumps that offer convenience and precision in insulin delivery. As the population of diabetes patients continues to grow, particularly in regions such as Asia-Pacific where the prevalence is rapidly increasing, the demand for disposable insulin pumps is expected to expand significantly, creating lucrative opportunities for manufacturers and healthcare providers in this evolving market.

• Rising Global Aging Population

The global aging population significantly influences the demand for easy-to-use insulin delivery devices, as older adults are more prone to diabetes and its associated complications. According to the World Health Organization (WHO), the number of people aged 60 and older is expected to reach 2.1 billion by 2050, representing a substantial increase from 1 billion in 2019. Such demographic shift is accompanied by a higher prevalence of diabetes, with estimates suggesting that approximately 10% of older adults are living with the condition. As managing diabetes becomes increasingly complex with age, there is a growing need for user-friendly insulin delivery systems, such as disposable insulin pumps, that offer simplicity and convenience.  Consequently, the demand for such solutions is expected to rise as healthcare providers aim to enhance the quality of life for older adults living with diabetes, ultimately driving the market.

Opportunities

• Rising Technological Advancements

Technological advancements in disposable insulin pump technology are significantly enhancing patient experiences through the incorporation of smart features such as remote monitoring and automated insulin delivery systems. For instance, the Medtronic MiniMed 770G system integrates continuous glucose monitoring (CGM) with an insulin pump, allowing for automated insulin delivery adjustments based on real-time glucose readings. This closed-loop system simplifies diabetes management for patients and helps maintain optimal glucose levels, reducing the risk of hypoglycemia. Furthermore, companies that focus on developing advanced algorithms and connectivity features, such as those that enable seamless integration with mobile applications, are poised to capitalize on this trend. As technology continues to evolve, these innovations represent substantial opportunities for companies to improve diabetes management and enhance patient adherence to treatment protocols.

• Increasing Healthcare Expenditure

Increased healthcare expenditure, especially in developed regions, plays a crucial role in fostering the adoption of advanced medical devices, such as disposable insulin pumps. According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending is projected to grow at an average rate of 5.4% annually, reaching approximately USD 6 trillion by 2027. Such surge in investment enhances access to innovative diabetes management solutions, as healthcare systems prioritize funding for technologies that improve patient outcomes and streamline care. For instance, initiatives that reimburse patients for the use of modern insulin delivery systems, including disposable insulin pumps, are becoming more common, allowing for broader access among diabetic patients. As a result, the growth in healthcare expenditure is directly correlated with improved access to effective diabetes care solutions, ultimately creating opportunities in the market.

Restraints/Challenges

• High Equipment Costs

The high cost of disposable insulin pumps serves as a significant market challenge, particularly for patients in regions with limited insurance coverage or considerable out-of-pocket expenses. As disposable insulin pumps can be prohibitively expensive, they become inaccessible to individuals with lower incomes or inadequate insurance plans. Consequently, many patients may opt for less expensive alternatives, such as traditional insulin syringes or pens, which, although effective, fail to provide the same level of convenience and efficiency in diabetes management. Such financial burden hinders the adoption of advanced insulin delivery systems and contributes to poorer health outcomes, as individuals unable to afford these technologies may struggle to maintain optimal blood glucose levels, thereby increasing their risk of diabetes-related complications.

• Limited Equipment Awareness

Limited awareness of disposable insulin pumps presents a notable challenge in their adoption, as both patients and healthcare providers may not fully understand the availability and benefits of these innovative devices. Despite their advantages, such as ease of use and improved diabetes management, many individuals continue to rely on traditional methods due to a lack of information. Such gap in awareness can result in missed opportunities for better glycemic control and overall health outcomes, as patients may struggle with the more cumbersome traditional methods. In addition, healthcare providers in these areas may not prioritize educating their patients about the latest technologies, further hampering the overall market expansion.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Disposable Insulin Pumps Market Scope

The market is segmented on the basis of type, products, accesories and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Patch pumps
• Tethered pumps

Product

• MiniMed
• Accu-Chek
• Tandem
• Omnipod
• others

Accessories

• Insulin Eeservoir or Cartridges
• Insulin Set Insertion Devices
• Battery

End-Users

• Hospitals and Clinics
• Home Care
• Laboratories

Disposable Insulin Pumps Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, products, accesories and end-users as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America stands out as the leading region in the market, primarily due to its well-established healthcare and medical facilities that ensure comprehensive patient care. The presence of major medical manufacturers and key players further enhances the region's dominance, facilitating innovation and access to advanced medical technologies. In addition, high healthcare expenditure in North America supports ongoing research and development, driving growth in the medical market.

Asia-Pacific region is projected to experience substantial growth during the forecast period from 2024 to 2031, largely driven by the rising prevalence of diabetes. As lifestyle changes and an aging population contribute to increasing diabetes rates, there is a growing demand for effective management and treatment solutions. This surge in demand is prompting healthcare providers and stakeholders in the region to invest in innovative diabetes care technologies and services, further fueling market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Disposable Insulin Pumps Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Disposable Insulin Pumps Market Leaders Operating in the Market Are:

• Medtronic (U.S.)
• Insulet Corporation (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• SOOIL Developments Co., Ltd (South Korea)
• Tandem Diabetes Care, Inc. (U.S.)
• SHINMYUNG MEDIYES CO., LTD. (South Korea)
• Debiotech SA (Switzerland)
• TOP Corporation (Japan)
• Kingfa Sci.&Tech. Co., Ltd (China)
• Sphere Fluidics (U.K.)
• Medsolve (UK) Limited (U.K.)
• Sanofi (France)
• Abbott (U.S.)
• BD (U.S.)

Latest Developments in Disposable Insulin Pumps Market

• In September 2024, Embecta Corp., a global leader in diabetes care with a century-long history in insulin delivery, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its innovative disposable insulin delivery system. Designed for adults managing diabetes, including both type 1 (T1D) and type 2 (T2D), this system features a tubeless patch pump design equipped with a 300-unit insulin reservoir, developed based on insights from individuals with T2D and their healthcare providers
• In March 2024, The FDA has cleared the twiist Automated Insulin Delivery (AID) system, marking it as the first insulin pump to integrate with Tidepool Loop. Approved for individuals with type 1 diabetes aged 6 and older, the twiist AID system, in conjunction with Tidepool Loop, provides precise microdosing capabilities, allows users to set a target as low as 87 mg/dL, and offers bolusing options based on various food types
• In January 2024, Medtronic plc, a global frontrunner in healthcare technology, has announced that it has received CE (Conformité Européenne) Mark approval for the MiniMed™ 780G system, which includes Simplera Sync, a disposable, all-in-one continuous glucose monitor (CGM) that eliminates the need for fingersticks or overtape. The Simplera Sync offers an enhanced user experience with a straightforward two-step insertion process and is half the size of earlier Medtronic sensors
• In December 2023, Medtronic has canceled its plans to acquire EOFlow, a company that manufactures an insulin patch pump currently involved in a patent dispute with Insulet. Medtronic cited “multiple breaches” of the agreements between the two companies as the reason for the decision. This year, EOFlow has faced ongoing patent litigation with Insulet
• In May 2023, Embecta has partnered with Tidepool to collaborate on the development of an innovative insulin pump designed to enhance diabetes management. This strategic alliance aims to integrate advanced technology and user-friendly features into the device, improving patient outcomes. In addition, Embecta has raised its growth outlook for the second quarter, reflecting confidence in its product pipeline and market demand

SKU-63894